CD96 and neoplasm: In humans, a significantly decreased percentage of CD96+ NK cells in pancreatic cancer patients and associations of this decreased percentage with lymph node metastasis and tumor histological grade were observed (64), suggesting a possible protective role for CD96+ NK cells in pancreatic cancer.